Sign up to save your podcasts
Or
Share TBT – The Top Papers of 2022
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
TBT – The Top Papers of 2022
Send us Fan Mail
Welcome back Rounds Table Listeners! As we approach the end of 2023, let’s revisit five important research studies from 2022: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (0:00 – 2:56) Tirzepatide Once Weekly for the Treatment of Obesity (2:56 – 6:00) Empagliflozin in Patients with Chronic Kidney Disease (6:00 – ...
The post TBT – The Top Papers of 2022 appeared first on Healthy Debate.
View all episodes
By Dr. John Fralick and Dr. Michael Fralick
5
1212 ratings
Send us Fan Mail
Welcome back Rounds Table Listeners! As we approach the end of 2023, let’s revisit five important research studies from 2022: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (0:00 – 2:56) Tirzepatide Once Weekly for the Treatment of Obesity (2:56 – 6:00) Empagliflozin in Patients with Chronic Kidney Disease (6:00 – ...
The post TBT – The Top Papers of 2022 appeared first on Healthy Debate.
More shows like The Rounds Table
View all
This American Life
91,297 Listeners
Radiolab
43,837 Listeners
NEJM This Week
321 Listeners
Emergency Medicine Cases
549 Listeners
AFP: American Family Physician Podcast
701 Listeners
JAMA Clinical Reviews
504 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
The Intern At Work: Internal Medicine
68 Listeners
The Clinical Problem Solvers
518 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Critical Care Scenarios
260 Listeners
The Cribsiders
320 Listeners
The Weekly Show with Jon Stewart
11,013 Listeners
What Now? with Trevor Noah
4,294 Listeners